Skip to main content

Advertisement

Table 1 Patient and disease characteristics at baseline

From: Profile and course of early rheumatoid arthritis in Morocco: a two-year follow-up study

Baseline variable Value
Sex, % women 88.2
Age, years 46.9 [24-72] ± 10.8
Provenance, % urban/rural 74.5/25.5
Education level  
Analphabet, % 68.6
High level school, % 3.9
Comorbidity, % 18.6
Disease duration, weeks 24 [6-48] ± 13.9
Referral to specialist delay, days 140 [7-420] ± 100
Stiffness duration, mn 138 [15-360] ± 76
Extraarticular manifestations, % 1.8
ESR, mm/hour 57.2 [5-115] ± 25.8
CRP, mg/liter 26.8 [0-96] ± 22
RF positivity, % 62.5
Antibody positivity, % 7.8
ACPA positivity, % 56.6
HLA-DRB1*04, % 45.1
HLA-DRB1*01, % 11.8
Patient global assessment (0-10) 3.4 [0-8] ± 1.6
Physician global assessment (0-10) 6.2 [1-10] ± 1.7
Patient pain assessment (0-10) 6.6 [1-10] ± 1.8
Tender joint count (0-28) 20.4 [8-48] ± 10.1
Swollen joint count (0-28) 9.6 ± 6.5
HAQ (0-3) 2.2 [0.7-3] ± 0.6
Presence at least of one erosion, % 27.5
Total SVDH score 1 (0-5)*
Erosion score 0 (0-1)*
Joint space narrowing score 1 (0-3)*
Treatment received  
Corticosteroids, % 35.3
DMARD, % 7.8
  1. Values are presented as mean or percentage.
  2. * Values are presented as median and quartiles.
  3. RA: Rheumatoid Arthritis: RF: Rheumatoid Factor; HAQ: Health Assessment Questionnaire; DAS 28: Disease Activity Score; ESR: erythrocyte sedimentation rate; CRP: C-reactive protein; DMARDs: Disease-Modifying Anti-Rheumatic Drugs.